Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04395508
Brief Title: An Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic

First Submitted : May 15, 2020
First Submitted that Met QC Criteria : May 19, 2020
First Posted : May 20, 2020

Last Update Submitted that Met QC Criteria : July 2, 2020
Last Update Posted : July 7, 2020